Parsons James T. - 21 Nov 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Scott Kellen, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
21 Nov 2025
Net transactions value
+$26,400
Form type
4
Filing time
25 Nov 2025, 16:30:55 UTC
Previous filing
03 Jun 2025
Next filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Parsons James T. Director 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS /s/ Scott Kellen, attorney-in-fact 25 Nov 2025 0001759855

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Common Stock Options Exercise $26,400 +12,000 +16% $2.20 87,854 21 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Options Exercise $0 -12,000 -100% $0.000000 0 21 Nov 2025 Common Shares 12,000 $2.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of the exercise price from CAD$ to US$ on the transaction date.
F2 Fully vested.